From start-ups to leading global companies, Greater Fort Lauderdale provides a stimulating and supportive business environment for success in the life sciences.

Duchenne muscular dystrophy

Catabasis routed after DMD trial failure

Catabasis lifted by early-stage muscular dystrophy data, but bigger test is coming soon

Sarepta jumps on J.P. Morgan update, gene therapy DMD deals

Shortened telomeres linked to heart damage in Duchenne muscular dystrophy

FDA expert lashes out at 'worrisome' Sarepta approval in JAMA

Small cap PTC tumbles as FDA rejects it again in Duchenne

Summit, Sarepta in $584M-plus DMD pipeline license pact in Europe

Sarepta CEO Ed Kaye on FDA courage, NICE and resilience

Sarepta not sure of patient numbers--but is sure of $300K-plus price tag